Berkeley startup, Magnetic Tides, has developed a new treatment for stroke patients
Briefly

Berkeley startup, Magnetic Tides, has developed a new treatment for stroke patients
"Each year, more than 795,000 people in the United States have a stroke equivalent to one stroke every 40 seconds. Every 3 minutes and 14 seconds, someone dies of stroke. Those who survive are often left with mobility challenges and other serious long-term disabilities. Research into potential stroke rehabilitation therapies from pharmaceuticals to electrical stimulation to robot-assisted gait training devices continues to yield creative new approaches."
"Magnetic Tides was co-founded in 2019 by three UC Berkeley scientists: Ludovica Labruna, the CEO; Daniel Sheltraw, the chief technology officer, and Richard Ivry, a professor of psychology and neuroscience. From left, Magnetic Tides founders Richard Ivry, Ludovica Labruna and Daniel Sheltraw. Credit: Kelly Sullivan Labruna came from Italy in 2006 to UC Berkeley for the final months of her Ph.D. to collaborate with Ivry in his Cognition and Action Lab."
"Working with the non-invasive brain stimulation devices that were on the market, we weren't able to replicate a lot of studies, said Labruna. I got very frustrated and I went to Daniel Sheltraw, who has expertise in magnetic resonance physics, and I asked him, How can we improve these devices?' And he told me, you can't do it. You have to build your own."
More than 795,000 Americans experience a stroke annually, leaving many survivors with mobility challenges and serious long-term disabilities; a stroke occurs every 40 seconds and kills someone every 3 minutes and 14 seconds. Research has produced pharmaceuticals, electrical stimulation, and robot-assisted gait devices, yet a non-invasive device that can target the brain for chronic stroke recovery remains lacking. Magnetic Tides, co-founded in 2019 by UC Berkeley scientists Ludovica Labruna, Daniel Sheltraw, and Richard Ivry, is developing a non-invasive magnetic-field brain stimulation device. Federal innovation grants funded prototype development at UC Berkeley, and the company aims to serve both research and chronic rehabilitation needs.
Read at www.berkeleyside.org
Unable to calculate read time
[
|
]